These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32157296)
1. An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia. Ko TK; Javed A; Lee KL; Pathiraja TN; Liu X; Malik S; Soh SX; Heng XT; Takahashi N; Tan JHJ; Bhatia R; Khng AJ; Chng WJ; Sia YY; Fruman DA; Ng KP; Chan ZE; Xie KJ; Hoi Q; Chan CX; Teo ASM; Velazquez Camacho O; Meah WY; Khor CC; Ong CTJ; Soon WJW; Tan P; Ng PC; Chuah C; Hillmer AM; Ong ST Blood; 2020 Jun; 135(26):2337-2353. PubMed ID: 32157296 [TBL] [Abstract][Full Text] [Related]
2. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation. Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872 [TBL] [Abstract][Full Text] [Related]
3. Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML). Desterke C; Voldoire M; Bonnet ML; Sorel N; Pagliaro S; Rahban H; Bennaceur-Griscelli A; Cayssials E; Chomel JC; Turhan AG Exp Hematol; 2018 Aug; 64():71-83.e8. PubMed ID: 29733872 [TBL] [Abstract][Full Text] [Related]
4. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia. Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728 [TBL] [Abstract][Full Text] [Related]
5. Loss of expression of both miR-15/16 loci in CML transition to blast crisis. Lovat F; Gasparini P; Nigita G; Larkin K; Byrd JC; Minden MD; Andreeff M; Carter BZ; Croce CM Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836616 [TBL] [Abstract][Full Text] [Related]
6. Absence of EZH2 gene mutation in chronic myeloid leukemia patients in blast crisis. Chen HY; Yao H; Wu LY; Liu CJ; Zhu JQ; Liu CH; Wang W; Dong SS; Ping NN; Chen SN; Sun M Asian Pac J Cancer Prev; 2013; 14(5):3375-6. PubMed ID: 23803132 [No Abstract] [Full Text] [Related]
7. Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model. Kazemi-Sefat GE; Keramatipour M; Vaezi M; Razavi SM; Kavousi K; Talebi A; Rostami S; Yaghmaie M; Chahardouli B; Talebi S; Mousavizadeh K Sci Rep; 2022 Jul; 12(1):12816. PubMed ID: 35896598 [TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Abrahamsson AE; Geron I; Gotlib J; Dao KH; Barroga CF; Newton IG; Giles FJ; Durocher J; Creusot RS; Karimi M; Jones C; Zehnder JL; Keating A; Negrin RS; Weissman IL; Jamieson CH Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3925-9. PubMed ID: 19237556 [TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo. Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations. Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566 [TBL] [Abstract][Full Text] [Related]
18. BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Bhattacharyya J; Mihara K; Yasunaga S; Tanaka H; Hoshi M; Takihara Y; Kimura A Ann Hematol; 2009 Apr; 88(4):333-40. PubMed ID: 18781299 [TBL] [Abstract][Full Text] [Related]
19. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy. Ferri C; Bianchini M; Bengió R; Larripa I Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144 [TBL] [Abstract][Full Text] [Related]
20. [Research advance on molecular genetics of CML blast crisis]. Zhu HQ; Zhang S; Liu XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]